The Evidence Speaks (January 2023)
The first Evidence Speaks of 2023 features mask mandate effectiveness, client preferences for iOAT delivery, and patient-reported outcomes following hysterectomy
Read MoreNovember 18, 2022
The first Evidence Speaks of 2023 features mask mandate effectiveness, client preferences for iOAT delivery, and patient-reported outcomes following hysterectomy
Read More
Discover new research on use of opioids and stimulants and risk of overdose, risk of heart conditions following second doses of COVID vaccines, and occupational and financial setbacks in caregivers of people with cancer
Read More
September's edition includes severity of the Omicron versus Delta COVID-19 variants, pre- and in-hospital factors that impact outcomes of cardiac arrest, and long-acting contraceptive use among Ugandan women
Read More
To mark Heart Month, this edition includes COVID-19's impact on heart attack care, the likelihood of cardiac arrest patients receiving EMS treatment, and risk of CVD among people with substance use disorder
Read More
This edition includes emergency contraception use in B.C., overdose following incarceration, and risk factors for hospitalization with COVID
Read More
This World Hepatitis Day we take a look at some of the most recent research to result from the BC Hepatitis Testers Cohort
Read More
CHÉOS Scientists are leading eight of the projects funded in this round, plus a further fourteen projects are supported by CHÉOS Scientists as co-investigators
Read More
To mark Kidney Health Month, this edition includes the safety of dialysis during COVID-19, corticosteroid use post-kidney transplant, and prescription patterns in dialysis patients
Read More
In recognition of World Hepatitis Day on July 28, CHÉOS Scientist Dr. Naveed Janjua discusses the BC Hepatitis Testers Cohort
Read More
This edition includes TB screening in people starting dialysis, early opioid dispensing after a lower back injury, and the burden and risk factors for HBV, HCV, and HIV in Rwanda
Read More